It is proposed that cyclooxygenase-2 (COX-2) inhibition can hasten Caspase-3 activation and poly (ADP-ribose) polymerase (PARP) cleavage, as well as suppress the expressions of anti-apoptotic proteins such as surviving, thus activating tumor apoptosis (5). The gene discussed is CASP3; the disease is neoplasm.